Researchers see benefit in keeping apple juice cloudy.
A serving of fruit juice is largely considered equivalent to a serving of whole fruit, but several components of fruits are removed during the juicing process. And they are usually full of nutrients. In the case of apple juice, numerous apple materials are discarded-some of which may even offer lipid-lowering benefits.
Previous studies suggest that apples and processed apple products contain nutrients that lower cholesterol absorption, but results are inconsistent. A team of European researchers realized that no human studies have looked at the lipid-lowering potential of whole apples versus their juices, nor of apple pomace-the pulpy byproduct of apple juice. In hopes of getting closer to the mystery of apple’s potential cholesterol benefit, the researchers assigned 23 volunteers to consume whole apples, apple pomace, clear or cloudy apple juice, or control for several weeks and in crossover fashion.
Compared to control, apple consumption resulted in a trend towards lowered total and LDL cholesterol-but only with whole apples (6.7%), pomace (7.9%), and cloudy juice (2.2%). Compared to whole apples and pomace, clear juice actually increased LDL cholesterol.
The less reduced forms of apple likely temper cholesterol because they contain pomace-and peel, in the case of whole apples-which offer ample amounts of pectin and polyphenols. These particular compounds may have cholesterol benefits of their own, based on previous research. The presence or absence of pulp, which contain these substances, is what creates the visual difference of cloudy apple juice and clear apple juice.
Based on their findings, the researchers conclude that clear apple juice “may not be a suitable surrogate” for the nutritional recommendations of whole fruit. Their findings are part of a larger movement of repurposing apple byproducts. One recent example is AppleActiv, an organic apple peel powder obtained from applesauce leftovers.
Robby Gardnerâ¨
Associate Editorâ¨
Nutritional Outlook magazineâ¨
robby.gardner@ubm.com
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.